Search research articles
Contact Us
Filters
Showing results (91-100 of 113) with videos related to
Page
of 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase
Timothy Hughes, Giuseppe Saglio, Susan Branford, et al.
Health Science Reports
|
April 17, 2026
AI in Mental Health: Transforming Diagnosis and Management of Depression and Anxiety
Tilyan Kambar, Sara Tariq, Saman Shahzad, et al.
Heliyon
|
January 26, 2022
Factors associated with suicidal behavior among university students in Bangladesh after one year of COVID-19 pandemic
Quazi Maksudur Rahman, Abid Hasan Khan, Abdullah Al Zubayer, et al.
The New England Journal of Medicine
|
June 8, 2010
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia
Giuseppe Saglio, Dong-Wook Kim, Surapol Issaragrisil, et al.
Molecular Metabolism
|
July 6, 2024
Metabolic profiling of single cells by exploiting NADH and FAD fluorescence via flow cytometry
Ariful Haque Abir, Leonie Weckwerth, Artur Wilhelm, et al.
Chemsuschem
|
June 17, 2021
Biotechnology of Plastic Waste Degradation, Recycling, and Valorization: Current Advances and Future Perspectives
Zi-Hao Qin, Jin-Hua Mou, Christopher Yu Huang Chao, et al.
Chemsuschem
|
September 14, 2021
Biotechnology of Plastic Waste Degradation, Recycling, and Valorization: Current Advances and Future Perspectives
Zi-Hao Qin, Jin-Hua Mou, Christopher Yu Huang Chao, et al.
Blood
|
August 24, 2007
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance
Hagop M Kantarjian, Francis Giles, Norbert Gattermann, et al.
International Journal for Equity in Health
|
January 20, 2025
Improving diagnostics and surveillance of malaria among displaced people in Africa
Toufik Abdul-Rahman, Oyinbolaji Akinwande Ajetunmobi, Gafar Babatunde Bamigbade, et al.
Vaccines
|
October 26, 2021
A Retrospective Cross-Sectional Study Assessing Self-Reported Adverse Events following Immunization (AEFI) of the COVID-19 Vaccine in Bangladesh
Arifa Sultana, Saimon Shahriar, Md Rafat Tahsin, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 113) with videos related to
Sort By:
Page
of 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 5, 2009
Impact of baseline BCR-ABL mutations on response to nilotinib in patients with chronic myeloid leukemia in chronic phase
Timothy Hughes, Giuseppe Saglio, Susan Branford, et al.
Health Science Reports
|
April 17, 2026
AI in Mental Health: Transforming Diagnosis and Management of Depression and Anxiety
Tilyan Kambar, Sara Tariq, Saman Shahzad, et al.
Heliyon
|
January 26, 2022
Factors associated with suicidal behavior among university students in Bangladesh after one year of COVID-19 pandemic
Quazi Maksudur Rahman, Abid Hasan Khan, Abdullah Al Zubayer, et al.
The New England Journal of Medicine
|
June 8, 2010
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia
Giuseppe Saglio, Dong-Wook Kim, Surapol Issaragrisil, et al.
Molecular Metabolism
|
July 6, 2024
Metabolic profiling of single cells by exploiting NADH and FAD fluorescence via flow cytometry
Ariful Haque Abir, Leonie Weckwerth, Artur Wilhelm, et al.
Chemsuschem
|
June 17, 2021
Biotechnology of Plastic Waste Degradation, Recycling, and Valorization: Current Advances and Future Perspectives
Zi-Hao Qin, Jin-Hua Mou, Christopher Yu Huang Chao, et al.
Chemsuschem
|
September 14, 2021
Biotechnology of Plastic Waste Degradation, Recycling, and Valorization: Current Advances and Future Perspectives
Zi-Hao Qin, Jin-Hua Mou, Christopher Yu Huang Chao, et al.
Blood
|
August 24, 2007
Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance
Hagop M Kantarjian, Francis Giles, Norbert Gattermann, et al.
International Journal for Equity in Health
|
January 20, 2025
Improving diagnostics and surveillance of malaria among displaced people in Africa
Toufik Abdul-Rahman, Oyinbolaji Akinwande Ajetunmobi, Gafar Babatunde Bamigbade, et al.
Vaccines
|
October 26, 2021
A Retrospective Cross-Sectional Study Assessing Self-Reported Adverse Events following Immunization (AEFI) of the COVID-19 Vaccine in Bangladesh
Arifa Sultana, Saimon Shahriar, Md Rafat Tahsin, et al.
Page
of 12